New Standard for Newly Diagnosed Pediatric B-Cell Acute Lymphoblastic Leukemia

(MedPage Today) -- SAN DIEGO -- Children with newly diagnosed B-cell acute lymphoblastic leukemia (B-ALL) lived significantly longer without disease recurrence when they received the bispecific T-cell engager blinatumomab (Blincyto) in addition...